The global pharmacovigilance market is expected to be worth USD 12.48 Billion by 2027, according to a current analysis by Emergen Research. The market for pharmacovigilance is experiencing rapid growth attributed to a rise in application for spontaneous reporting, electronic health record (HER) mining, cohort event monitoring, and intensified adverse drug reaction (ADR) reporting, among others.
https://www.emergenresearch.co....m/industry-report/ph
![image](https://posta2z.com/upload/photos/2022/05/YCX6bhjgM1eSWDpUSarM_16_cd62ee9d4c90d5db97180ab8254dac96_image.jpg)